A cohort study measuring SARS-CoV-2 seroconversion and serial viral testing in university students
暂无分享,去创建一个
P. Remington | J. Tate | D. Currie | R. Westergaard | Clint N. Morgan | H. Segaloff | J. Bigouette | A. Bateman | J. Kahrs | K. Langolf | Christopher H. Hsu | H. Kirking | Rodel Desamu-Thorpe | G. Abedi | M. Foster | Devlin Cole | T. Whyte | Alana Sterkel | H. G. Rosenblum | Patrick Kelly | Christine C Lee | Tarah Somers | J. Ruff | David Payne | H. Rosenblum | D. Payne
[1] Amanda M Jovaag,et al. Interventions to Disrupt Coronavirus Disease Transmission at a University, Wisconsin, USA, August–October 2020 , 2021, Emerging infectious diseases.
[2] P. Remington,et al. Risk Factors for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and Presence of Anti–SARS-CoV-2 Antibodies Among University Student Dormitory Residents, September–November 2020 , 2021, Open forum infectious diseases.
[3] J. Rassen,et al. Association of SARS-CoV-2 Seropositive Antibody Test With Risk of Future Infection , 2021, JAMA internal medicine.
[4] R. Westergaard,et al. Trends in Outbreak-Associated Cases of COVID-19 — Wisconsin, March–November 2020 , 2021, MMWR. Morbidity and mortality weekly report.
[5] Krista K. Proia,et al. COVID-19 Trends Among Persons Aged 0–24 Years — United States, March 1–December 12, 2020 , 2021, MMWR. Morbidity and mortality weekly report.
[6] M. Nussenzweig,et al. Evolution of antibody immunity to SARS-CoV-2 , 2021, Nature.
[7] A. Sette,et al. Adaptive immunity to SARS-CoV-2 and COVID-19 , 2021, Cell.
[8] V. Allen,et al. SARS-CoV-2 seroprevalence survey estimates are affected by anti-nucleocapsid antibody decline. , 2021, The Journal of infectious diseases.
[9] M. Killerby,et al. Performance of an Antigen-Based Test for Asymptomatic and Symptomatic SARS-CoV-2 Testing at Two University Campuses — Wisconsin, September–October 2020 , 2021, MMWR. Morbidity and mortality weekly report.
[10] D. Stuart,et al. Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers , 2020, The New England journal of medicine.
[11] R. Tibshirani,et al. Defining the features and duration of antibody responses to SARS-CoV-2 infection associated with disease severity and outcome , 2020, Science Immunology.
[12] R. Hasnain-Wynia,et al. Disproportionate Incidence of COVID-19 Infection, Hospitalizations, and Deaths Among Persons Identifying as Hispanic or Latino — Denver, Colorado March–October 2020 , 2020, MMWR. Morbidity and mortality weekly report.
[13] Samuel M. Brown,et al. Decline in SARS-CoV-2 Antibodies After Mild Infection Among Frontline Health Care Personnel in a Multistate Hospital Network — 12 States, April–August 2020 , 2020, MMWR. Morbidity and mortality weekly report.
[14] Z. Livneh,et al. Multi-center nationwide comparison of seven serology assays reveals a SARS-CoV-2 non-responding seronegative subpopulation , 2020, EClinicalMedicine.
[15] L. Grohskopf,et al. Lack of antibodies to SARS-CoV-2 in a large cohort of previously infected persons , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[16] B. Wolff,et al. COVID-19 Mitigation Behaviors by Age Group — United States, April–June 2020 , 2020, MMWR. Morbidity and mortality weekly report.
[17] C. Cordon-Cardo,et al. Robust neutralizing antibodies to SARS-CoV-2 infection persist for months , 2020, Science.
[18] M. Malim,et al. Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans , 2020, Nature Microbiology.
[19] P. G. Choe,et al. Waning Antibody Responses in Asymptomatic and Symptomatic SARS-CoV-2 Infection , 2020, Emerging infectious diseases.
[20] B. Zhang,et al. Antibody dynamics to SARS‐CoV‐2 in asymptomatic COVID‐19 infections , 2020, Allergy.
[21] G. Rodger,et al. Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison , 2020, The Lancet Infectious Diseases.
[22] D. Cummings,et al. A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity , 2020, Nature Communications.
[23] C. Blackmore,et al. Disparities in Incidence of COVID-19 Among Underrepresented Racial/Ethnic Groups in Counties Identified as Hotspots During June 5–18, 2020 — 22 States, February–June 2020 , 2020, MMWR. Morbidity and mortality weekly report.
[24] Otto O. Yang,et al. Rapid Decay of Anti–SARS-CoV-2 Antibodies in Persons with Mild Covid-19 , 2020, The New England journal of medicine.
[25] Morten Nielsen,et al. Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19 , 2020, Cell.
[26] Harnish Mukesh Naik,et al. Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population , 2020, medRxiv.
[27] S. Lee,et al. Antibody Responses to SARS-CoV-2 at 8 Weeks Postinfection in Asymptomatic Patients , 2020, Emerging infectious diseases.
[28] Y. Tie,et al. Coronavirus Disease 2019 Case Surveillance — United States, January 22–May 30, 2020 , 2020, MMWR. Morbidity and mortality weekly report.
[29] P. Tambyah,et al. Clinical evaluation of serological IgG antibody response on the Abbott Architect for established SARS-CoV-2 infection , 2020, Clinical Microbiology and Infection.
[30] G. Alter,et al. Dissecting antibody-mediated protection against SARS-CoV-2 , 2020, Nature Reviews Immunology.
[31] R. Davey,et al. Sensitivity in Detection of Antibodies to Nucleocapsid and Spike Proteins of Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Coronavirus Disease 2019 , 2020, The Journal of Infectious Diseases.
[32] Anna María Nápoles,et al. COVID-19 and Racial/Ethnic Disparities. , 2020, JAMA.
[33] Jun Yuan,et al. Antibody responses to SARS-CoV-2 in patients with COVID-19 , 2020, Nature Medicine.
[34] Lei Liu,et al. Profile of IgG and IgM antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[35] J. Adams. Institutions of higher education , 2019, Emerging Voices in Natural Hazards Research.
[36] Publisher's Note , 2018, Anaesthesia.